Published :
Tables : 56
Figures : 43
Category : Healthcare
No. of Pages : 225
Report Code : HC-U3133
Next Generation Sequencing Market Overview: Improvements in the reimbursement and regulation for Next Generation Sequencing (NGS) -based tests coupled with the declining costs of platforms created for NGS are some of the important factors responsible for the growth of the market. The Sequencing By Synthesis (SBS) segment is predicted to proliferate with a remarkable growth rate owing to the increased demand for systems developed by Illumina, who are the primary providers of NGS platforms that are integrated with SBS technology. Moreover, with an ongoing research for developing advanced NGS platforms, this segment is poised to grow further over the forecast period. North America accounts for the largest market share, which is followed by Europe. This is primarily due to factors like the availability of funds that can be utilised for research in diagnostics and genomics. Furthermore, the development of solutions for analysing NGS data shall boost the growth of the market in this region. FutureWise Market Research has instantiated a report that provides an intricate analysis of Next Generation Sequencing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Next Generation Sequencing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Next Generation Sequencing Market • Illumina Inc. • Thermo Fisher Scientific Inc. • BGI Group • Perkinelmer • Agilent Technologies • Qiagen N.v • F-hoffmann La Roche Ag • Genewiz • Eurofins Scientific • Psomagen Inc. • Oxford Nanopore Technologies • 10x Genomics • Takara Bio • Zymo Research • Nugen Technologies • Hamilton Company • Beckman Coulter (A Subsidiary of Danaher) • Becton, Dickinson and Company • Genotypic Technology • Lucigen Corporation (Note: The list of the major players will be updated with the latest market scenario and trends) Next Generation Sequencing Market Segmentation: By Product & Service • Presequencing Products & Services o Library Preparation & Target Enrichment o Quality Control • NGS consumables • NGS Platforms o Illumina o HiSeq Systems o HiSeq X Ten & HiSeq X Five o MiSeq Systems o NextSeq Systems o MiniSeq Systems o NovaSeq Systems o iSeq 100 Systems o Thermo Fisher Scientific o Ion PGM Systems o Ion Proton Systems o Ion GeneStudio S5 Systems o Pacific Biosciences o PacBio RS II Systems o Sequel Systems o Oxford Nanopore Technologies o Other NGS Platforms • Services for NGS Platforms • Sequencing Services o Exome & Targeted Resequencing and Custom Panels o RNA-Seq o Whole-genome Sequencing and De Novo Sequencing o Other Sequencing Services • Bioinformatics o Data Analysis Software & Workbenches o Data Analysis Services o Storage, Management, and Cloud Computing Solutions By Technology • Sequencing by Synthesis • Ion Semiconductor Sequencing • Single-molecule Real-time Sequencing • Nanopore Sequencing • Other Sequencing Technologies By Application • Diagnostics o Cancer Diagnostics o Reproductive Health Diagnostics o Infectious Disease Diagnostics o Other Diagnostic Applications • Drug Discovery • Agriculture & Animal Research • Other Applications By End User • Academic Institutes and Research Centers • Pharmaceutical and Biotech Companies • Hospitals and Clinics • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Next-generation Sequencing Market By Product & Service, By Technology, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- Product & Service launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Improvements in the reimbursement and regulation for Next Generation Sequencing (NGS) -based tests coupled with the declining costs of platforms created for NGS are some of the important factors responsible for the growth of the market.
The Sequencing By Synthesis (SBS) segment is predicted to proliferate with a remarkable growth rate owing to the increased demand for systems developed by Illumina, who are the primary providers of NGS platforms that are integrated with SBS technology. Moreover, with an ongoing research for developing advanced NGS platforms, this segment is poised to grow further over the forecast period.
North America accounts for the largest market share, which is followed by Europe. This is primarily due to factors like the availability of funds that can be utilised for research in diagnostics and genomics. Furthermore, the development of solutions for analysing NGS data shall boost the growth of the market in this region.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Next Generation Sequencing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Next Generation Sequencing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Next Generation Sequencing Market
• Illumina Inc. • Thermo Fisher Scientific Inc. • BGI Group • Perkinelmer • Agilent Technologies • Qiagen N.v • F-hoffmann La Roche Ag • Genewiz • Eurofins Scientific • Psomagen Inc. • Oxford Nanopore Technologies • 10x Genomics • Takara Bio • Zymo Research • Nugen Technologies • Hamilton Company • Beckman Coulter (A Subsidiary of Danaher) • Becton, Dickinson and Company • Genotypic Technology • Lucigen Corporation (Note: The list of the major players will be updated with the latest market scenario and trends)
Next Generation Sequencing Market Segmentation: By Product & Service • Presequencing Products & Services o Library Preparation & Target Enrichment o Quality Control • NGS consumables • NGS Platforms o Illumina o HiSeq Systems o HiSeq X Ten & HiSeq X Five o MiSeq Systems o NextSeq Systems o MiniSeq Systems o NovaSeq Systems o iSeq 100 Systems o Thermo Fisher Scientific o Ion PGM Systems o Ion Proton Systems o Ion GeneStudio S5 Systems o Pacific Biosciences o PacBio RS II Systems o Sequel Systems o Oxford Nanopore Technologies o Other NGS Platforms • Services for NGS Platforms • Sequencing Services o Exome & Targeted Resequencing and Custom Panels o RNA-Seq o Whole-genome Sequencing and De Novo Sequencing o Other Sequencing Services • Bioinformatics o Data Analysis Software & Workbenches o Data Analysis Services o Storage, Management, and Cloud Computing Solutions
By Technology • Sequencing by Synthesis • Ion Semiconductor Sequencing • Single-molecule Real-time Sequencing • Nanopore Sequencing • Other Sequencing Technologies
By Application • Diagnostics o Cancer Diagnostics o Reproductive Health Diagnostics o Infectious Disease Diagnostics o Other Diagnostic Applications • Drug Discovery • Agriculture & Animal Research • Other Applications
By End User • Academic Institutes and Research Centers • Pharmaceutical and Biotech Companies • Hospitals and Clinics • Others
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Next-generation Sequencing Market By Product & Service, By Technology, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- Product & Service launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Next Generation Sequencing Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Next Generation Sequencing Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Next Generation Sequencing Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Next Generation Sequencing Market, By Products and Services Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Presequencing Products & Services 7.1.1. Library Preparation & Target Enrichment 7.1.2. Quality Control 7.2. NGS consumables 7.3. NGS Platforms 7.3.1. Illumina 7.3.1.1. HiSeq Systems 7.3.1.2. HiSeq X Ten & HiSeq X Five 7.3.1.3. MiSeq Systems 7.3.1.4. NextSeq Systems 7.3.1.5. MiniSeq Systems 7.3.1.6. NovaSeq Systems 7.3.1.7. iSeq 100 Systems 7.3.2. Thermo Fisher Scientific 7.3.2.1. Ion PGM Systems 7.3.2.2. Ion Proton Systems 7.3.2.3. Ion GeneStudio S5 Systems 7.3.3. Pacific Biosciences 7.3.3.1. PacBio RS II Systems 7.3.3.2. Sequel Systems 7.3.4. Oxford Nanopore Technologies 7.3.5. Other NGS Platforms 7.4. Services for NGS Platforms 7.5. Sequencing Services 7.5.1. Exome & Targeted Resequencing and Custom Panels 7.5.2. RNA-Seq 7.5.3. Whole-genome Sequencing and De Novo Sequencing 7.5.4. Other Sequencing Services 7.6. Bioinformatics 7.6.1. Data Analysis Software & Workbenches 7.6.2. Data Analysis Services 7.6.3. Storage, Management, and Cloud Computing Solutions 8. Next Generation Sequencing Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Sequencing by Synthesis 8.2. Ion Semiconductor Sequencing 8.3. Single-molecule Real-time Sequencing 8.4. Nanopore Sequencing 8.5. Other Sequencing Technologies 9. Next Generation Sequencing Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Diagnostics 9.1.1. Cancer Diagnostics 9.1.2. Reproductive Health Diagnostics 9.1.3. Infectious Disease Diagnostics 9.1.4. Other Diagnostic Applications 9.2. Drug Discovery 9.3. Agriculture & Animal Research 9.4. Other Applications 10. Next Generation Sequencing Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Academic Institutes and Research Centers 10.2. Pharmaceutical and Biotech Companies 10.3. Hospitals and Clinics 10.4. Others 11. North America Next Generation Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028 12. Latin America Next Generation Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Europe Next Generation Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028 14. Asia Pacific Next Generation Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Illumina Inc. 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Thermo Fisher Scientific Inc. 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. BGI Group 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Perkinelmer 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Agilent Technologies 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Qiagen N.v 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. F-hoffmann La Roche Ag 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Genewiz 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Eurofins Scientific 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Psomagen Inc. 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11.Oxford Nanopore Technologies 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12.10x Genomics 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13.Takara Bio 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14.Zymo Research 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 17.15.Nugen Technologies (A Part of Tecan Trading AG) 17.15.1. Company Overview 17.15.2. Product Portfolio 17.15.3. SWOT Analysis 17.15.4. Financial Overview 17.15.5. Strategic Overview 17.16.Hamilton Company 17.16.1. Company Overview 17.16.2. Product Portfolio 17.16.3. SWOT Analysis 17.16.4. Financial Overview 17.16.5. Strategic Overview 17.17.Beckman Coulter (A Subsidiary of Danaher) 17.17.1. Company Overview 17.17.2. Product Portfolio 17.17.3. SWOT Analysis 17.17.4. Financial Overview 17.17.5. Strategic Overview 17.18.Becton, Dickinson and Company 17.18.1. Company Overview 17.18.2. Product Portfolio 17.18.3. SWOT Analysis 17.18.4. Financial Overview 17.18.5. Strategic Overview 17.19.Genotypic Technology 17.19.1. Company Overview 17.19.2. Product Portfolio 17.19.3. SWOT Analysis 17.19.4. Financial Overview 17.19.5. Strategic Overview 17.20.Genotypic Technology 17.20.1. Company Overview 17.20.2. Product & Service Portfolio 17.20.3. SWOT Analysis 17.20.4. Financial Overview 17.20.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Next Generation Sequencing Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Next Generation Sequencing Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Next Generation Sequencing Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Next Generation Sequencing Market, By Products and Services Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Presequencing Products & Services 7.1.1. Library Preparation & Target Enrichment 7.1.2. Quality Control 7.2. NGS consumables 7.3. NGS Platforms 7.3.1. Illumina 7.3.1.1. HiSeq Systems 7.3.1.2. HiSeq X Ten & HiSeq X Five 7.3.1.3. MiSeq Systems 7.3.1.4. NextSeq Systems 7.3.1.5. MiniSeq Systems 7.3.1.6. NovaSeq Systems 7.3.1.7. iSeq 100 Systems 7.3.2. Thermo Fisher Scientific 7.3.2.1. Ion PGM Systems 7.3.2.2. Ion Proton Systems 7.3.2.3. Ion GeneStudio S5 Systems 7.3.3. Pacific Biosciences 7.3.3.1. PacBio RS II Systems 7.3.3.2. Sequel Systems 7.3.4. Oxford Nanopore Technologies 7.3.5. Other NGS Platforms 7.4. Services for NGS Platforms 7.5. Sequencing Services 7.5.1. Exome & Targeted Resequencing and Custom Panels 7.5.2. RNA-Seq 7.5.3. Whole-genome Sequencing and De Novo Sequencing 7.5.4. Other Sequencing Services 7.6. Bioinformatics 7.6.1. Data Analysis Software & Workbenches 7.6.2. Data Analysis Services 7.6.3. Storage, Management, and Cloud Computing Solutions
8. Next Generation Sequencing Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Sequencing by Synthesis 8.2. Ion Semiconductor Sequencing 8.3. Single-molecule Real-time Sequencing 8.4. Nanopore Sequencing 8.5. Other Sequencing Technologies
9. Next Generation Sequencing Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Diagnostics 9.1.1. Cancer Diagnostics 9.1.2. Reproductive Health Diagnostics 9.1.3. Infectious Disease Diagnostics 9.1.4. Other Diagnostic Applications 9.2. Drug Discovery 9.3. Agriculture & Animal Research 9.4. Other Applications
10. Next Generation Sequencing Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Academic Institutes and Research Centers 10.2. Pharmaceutical and Biotech Companies 10.3. Hospitals and Clinics 10.4. Others
11. North America Next Generation Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Next Generation Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Next Generation Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Next Generation Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Illumina Inc. 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Thermo Fisher Scientific Inc. 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. BGI Group 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Perkinelmer 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Agilent Technologies 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Qiagen N.v 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. F-hoffmann La Roche Ag 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Genewiz 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Eurofins Scientific 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Psomagen Inc. 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11.Oxford Nanopore Technologies 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12.10x Genomics 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13.Takara Bio 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14.Zymo Research 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 17.15.Nugen Technologies (A Part of Tecan Trading AG) 17.15.1. Company Overview 17.15.2. Product Portfolio 17.15.3. SWOT Analysis 17.15.4. Financial Overview 17.15.5. Strategic Overview 17.16.Hamilton Company 17.16.1. Company Overview 17.16.2. Product Portfolio 17.16.3. SWOT Analysis 17.16.4. Financial Overview 17.16.5. Strategic Overview 17.17.Beckman Coulter (A Subsidiary of Danaher) 17.17.1. Company Overview 17.17.2. Product Portfolio 17.17.3. SWOT Analysis 17.17.4. Financial Overview 17.17.5. Strategic Overview 17.18.Becton, Dickinson and Company 17.18.1. Company Overview 17.18.2. Product Portfolio 17.18.3. SWOT Analysis 17.18.4. Financial Overview 17.18.5. Strategic Overview 17.19.Genotypic Technology 17.19.1. Company Overview 17.19.2. Product Portfolio 17.19.3. SWOT Analysis 17.19.4. Financial Overview 17.19.5. Strategic Overview 17.20.Genotypic Technology 17.20.1. Company Overview 17.20.2. Product & Service Portfolio 17.20.3. SWOT Analysis 17.20.4. Financial Overview 17.20.5. Strategic Overview
18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics